BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cytognos, S.L. - ECPv4.9.7//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cytognos, S.L.
X-ORIGINAL-URL:https://www.cytognos.com
X-WR-CALDESC:Events for Cytognos, S.L.
BEGIN:VTIMEZONE
TZID:"Europe/Paris"
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210428
DTEND;VALUE=DATE:20210429
DTSTAMP:20260425T184653
CREATED:20210414T143944Z
LAST-MODIFIED:20210415T114556Z
UID:16974-1619568000-1619654399@www.cytognos.com
SUMMARY:Webinar - Bench to bedside: transitioning MRD NGF from research to CAP/CLIA accredited environment - 1 PM EST
DESCRIPTION:Join us for a 1-hour webinar \nLaboratory Developed Test (LDT) validation is one of the most challenging aspects of the implementation of a Next Generation Flow (NGF) assay. In this webinar\, David M Foureau will discuss how he navigated the process of validating a high sensitive Multiple Myeloma MRD flow assay following CAP/CLIA standards and how he successfully bridged the gap between the flow laboratory and the clinic. \nKey learning points: \n\nShort overview of MRD testing in Multiple Myeloma\nResearch insights on MRD NGF specimen collection and adequacy\nResearch insights on MRD NGF assay performance\nBuilding a clinical validation plan for flow cytometry-based assay\nMRD NGF clinical validation highlights (specificity\, sensitivity\, robustness)\nGeneral considerations on running MRD NGF clinical test\n\nCurrently working as the Research Group Director at the Levine Cancer Institute (Atrium Health)\, in 2013 David M Foureau created the Immune Monitoring Core Laboratory at Atrium Health (formerly Carolinas Healthcare System) which is specialized in immunoassay development\, validation and implementation for immune-oncology applications. \n7 PM GMT+2 (Madrid\, Spain)\n7 PM GMT+2 (Amsterdam\, Netherlands)\n1 AM GMT+8 (Beijing\, China)\n3 AM GMT +1 (Sydney\, Australia)\n2 PM GMT-3 (Rio de Janeiro\, Brasil)\n1 PM GMT-4 (New York\, NY\, USA)\n10 AM GMT-7 (Los Angeles\, CA\, USA)\n5 PM GMT (London\, United Kingdom) \n.fusion-button.button-1 .fusion-button-text\, .fusion-button.button-1 i {color:#bb0000;}.fusion-button.button-1 {border-width:1px;border-color:#bb0000;}.fusion-button.button-1 .fusion-button-icon-divider{border-color:#bb0000;}.fusion-button.button-1:hover .fusion-button-text\, .fusion-button.button-1:hover i\,.fusion-button.button-1:focus .fusion-button-text\, .fusion-button.button-1:focus i\,.fusion-button.button-1:active .fusion-button-text\, .fusion-button.button-1:active{color:#bb0000;}.fusion-button.button-1:hover\, .fusion-button.button-1:focus\, .fusion-button.button-1:active{border-width:1px;border-color:#bb0000;}.fusion-button.button-1:hover .fusion-button-icon-divider\, .fusion-button.button-1:hover .fusion-button-icon-divider\, .fusion-button.button-1:active .fusion-button-icon-divider{border-color:#bb0000;}.fusion-button.button-1 .fusion-button-text {text-transform:uppercase;}.fusion-button.button-1{width:auto;}Check your local time\n\n\n
URL:https://www.cytognos.com/event/webinar-bench-to-bedside-transitioning-mrd-ngf-from-research-to-cap-clia-accredited-environment-1-pm-est/
CATEGORIES:Webinars
ATTACH;FMTTYPE=image/png:https://www.cytognos.com/wp-content/uploads/Webinar-David-Fureau-min.png
END:VEVENT
END:VCALENDAR